| Application no. and date | 05741185.2 (espacenet) (Federated) (European Patent Register), 20050517 | | Patent/reg. no. and date | DK/EP 1753760, 20080102 | | Publication date | 20070221 | | Priority no. and date | EP 04102262, 20040524 | | EP pub. no. and date |
EP 1753760 20070221 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Base, CH | | Applicant ref. no. | P43525DK01 | | Inventor | FLOHR, Alexander, Passwangstrasse 3
CH-4153 Reinach, CH,
POLI, Sonia, Maria, Chemin de Montesquion 66
CH-1213 Onex-Geneve, CH,
STEWARD, Lucinda, Im tiefen Boden 23
CH-4059 Basel, CH,
RIEMER, Claus, Dreikoenigstrasse 31
79102 Freiburg, DE,
MOREAU, Jean-Luc, 8, rue de la Paix
F-68460 Lutterbach, FR | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61P 25/28 (2006.01) , A61P 25/36 (2006.01) , C07D 417/12 (2006.01) | | Title | 4-hydroxy-4-methyl-piperidin-1-carboxylsyre-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amid
| | Int. application no. | EP2005005329 | | Int. publication no. | WO2005116026 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
